These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20506673)

  • 21. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of endocervical curettage: does routine ECC at the time of colposcopy for low-grade cytologic abnormalities improve diagnosis of high-grade disease?
    Rose JD; Byun SY; Sims SM; Davis JD
    Am J Obstet Gynecol; 2012 Jun; 206(6):530.e1-3. PubMed ID: 22541611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cervical conization in dysplasia and carcinoma in situ. Role of concomitant uterine curettage].
    Kazadi Buanga J; Acosta Vazquez MJ
    Rev Fr Gynecol Obstet; 1994 Dec; 89(12):602-5. PubMed ID: 7846467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cryosurgery in the treatment of intraepithelial neoplasia of the uterine cervix.
    Javaheri G; Balin M; Meltzer RM
    Obstet Gynecol; 1981 Jul; 58(1):83-7. PubMed ID: 7243149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for residual disease in subsequent hysterectomy following conization for CIN III.
    Lu CH; Liu FS; Tseng JJ; Ho ES
    Gynecol Oncol; 2000 Nov; 79(2):284-8. PubMed ID: 11063658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of endocervical curettage in colposcopy.
    Hatch KD; Shingleton HM; Orr JW; Gore H; Soong SJ
    Obstet Gynecol; 1985 Mar; 65(3):403-8. PubMed ID: 3974966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of endocervical curettage after conization for cervical intraepithelial neoplasia.
    Schneider P; von Orelli S; Roos M; Leo C; Fink D; Wyss P
    Ann Diagn Pathol; 2012 Aug; 16(4):245-9. PubMed ID: 22115536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting persistent/recurrent disease in the cervix after excisional biopsy.
    Ramchandani SM; Houck KL; Hernandez E; Gaughan JP
    MedGenMed; 2007 Apr; 9(2):24. PubMed ID: 17955080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocervical brush cytology. An alternative to endocervical curettage?
    Weitzman GA; Korhonen MO; Reeves KO; Irwin JF; Carter TS; Kaufman RH
    J Reprod Med; 1988 Aug; 33(8):677-83. PubMed ID: 3172071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.
    Roman LD; Felix JC; Muderspach LI; Agahjanian A; Qian D; Morrow CP
    Obstet Gynecol; 1997 Nov; 90(5):759-64. PubMed ID: 9351760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.
    Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; ten Kate FW; ter Schegget J; Bleker OP
    Gynecol Oncol; 1999 Feb; 72(2):199-201. PubMed ID: 10021301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hysterectomy in invasive cervical cancer: a national patterns of care study of the American College of Surgeons.
    Shingleton HM; Jones WB; Russell A; Fremgen A; Chmiel JS; Ocwieja K; Winchester DP; Clive R
    J Am Coll Surg; 1996 Oct; 183(4):393-400. PubMed ID: 8843270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative management of intraepithelial cervical neoplasia.
    Lickrish GM; Fortier M
    Can Med Assoc J; 1977 Mar; 116(6):641-3. PubMed ID: 608164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endocervical curettage. Its use in the colposcopic assessment of a patient who has an abnormal cervico-vaginal smear].
    Bergeron C
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):989-94. PubMed ID: 2081876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between loop diathermy conization and cold-knife conization for management of cervical dysplasia associated with unsatisfactory colposcopy.
    Oyesanya OA; Amerasinghe C; Manning EA
    Gynecol Oncol; 1993 Jul; 50(1):84-8. PubMed ID: 8349168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of endocervical curettage at time of cervical cone biopsy.
    Spann CO; Brown T; Kennedy JE; Wheeless CR
    J Natl Med Assoc; 1993 Feb; 85(2):117-9. PubMed ID: 8441187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.